(Q34134983)

31 July 2017

Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study (English)

1 reference

31 July 2017

0 references

0 references

1 reference

Khalifa E Sharquie

1

1 reference

PubMed ID

12081158

31 July 2017

Rafid A Najim

series ordinal

2

1 reference

PubMed ID

12081158

31 July 2017

Ahmed R Abu-Raghif

series ordinal

3

1 reference

31 July 2017

1 May 2002

1 reference

The Journal of Dermatology

31 July 2017

1 reference

31 July 2017

29

1 reference

31 July 2017

5

1 reference

31 July 2017

267-279

1 reference

Sensitivity and specificity of different diagnostic criteria for Behçet's disease according to the latent class approach.

31 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2002.TB00263.X

Crossref

reference URL

The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2002.TB00263.X

Crossref

reference URL

In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2002.TB00263.X

Crossref

reference URL

10.1111/J.1346-8138.2002.TB00263.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12081158